π Local Job Near You
Clinical Director (Principal Scientist), Translational Medicine, Immunology
Merck
π
Upper Gwynedd, United States
Location
Upper Gwynedd
Posted
June 24, 2026
Commute
Local Area
Local Opportunity Near You!
This job is in your area. Enjoy a short commute and work close to home.
Job Description
**Job Description**
Translational Medicine is responsible for early clinical development of novel therapeutics, working in close collaboration with Immunology Discovery Sciences and late-stage Immunology Clinical Research. We work with all therapeutic areas within our Research Division with the role focused on Immunology. Principal Scientist (Medical Director level or known internally as Clinical Directors) must have a strong background in basic and/or clinical translational research and a desire to work collaboratively across different therapeutic areas
**Translational Medicine is specifically responsible for:**
β’ Leadership of the early clinical development strategy for novel therapy programs from Preclinical Candidate approval through Clinical Pharmacology testing (Phase 1), and clinical Proof-of-Concept (Phase 2).
β’ Development of biomarker strategies through cross-functional teams that provide line-of-sight from First-in-Human studie...
Translational Medicine is responsible for early clinical development of novel therapeutics, working in close collaboration with Immunology Discovery Sciences and late-stage Immunology Clinical Research. We work with all therapeutic areas within our Research Division with the role focused on Immunology. Principal Scientist (Medical Director level or known internally as Clinical Directors) must have a strong background in basic and/or clinical translational research and a desire to work collaboratively across different therapeutic areas
**Translational Medicine is specifically responsible for:**
β’ Leadership of the early clinical development strategy for novel therapy programs from Preclinical Candidate approval through Clinical Pharmacology testing (Phase 1), and clinical Proof-of-Concept (Phase 2).
β’ Development of biomarker strategies through cross-functional teams that provide line-of-sight from First-in-Human studie...